Page last updated: 2024-10-25

deferoxamine and Myoclonic Jerk

deferoxamine has been researched along with Myoclonic Jerk in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
"We describe a patient undergoing chronic hemodialysis who developed a neurologic syndrome consisting of seizures, progressive myoclonus, and mild dementia and who responded to chelation therapy with deferoxamine mesylate."3.67Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity. ( Corwin, HL; Mayor, GH; Sprague, SM; Tanner, CM; Wilson, RS, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogura, Y1
Yokoyama, K1
Ohara, M1
Sprague, SM1
Corwin, HL1
Wilson, RS1
Mayor, GH1
Tanner, CM1

Other Studies

2 other studies available for deferoxamine and Myoclonic Jerk

ArticleYear
[Dialysis encephalopathy].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl

    Topics: Anticonvulsants; Apraxias; Deferoxamine; Dementia; Electroencephalography; Humans; Kidney Failure, C

1992
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
    Archives of internal medicine, 1986, Volume: 146, Issue:10

    Topics: Aluminum; Deferoxamine; Dementia; Female; Humans; Kidney Failure, Chronic; Middle Aged; Myoclonus; R

1986